(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||
Cash flow from continuing operating activities | 114.98%41.93K | 3.54%-623.31K | -426.69%-93.09K | -666,657.14%-279.95K | -64,615,400.00%-646.16K | 28.5K | 42 | -1 |
Net income from continuing operations | 28.26%-143.44K | 63.65%-679.6K | -1,454.93%-142.23K | -1,110,733.33%-199.95K | -48,272.70%-1.87M | ---9.15K | ---18 | ---3.87K |
Operating gains losses | ---- | ---59.93K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 99.49%22.64K | 263.55%82.5K | --35.97K | --11.35K | --22.69K | --0 | --0 | --0 |
Remuneration paid in stock | ---- | -98.35%22.01K | ---- | ---- | --1.34M | ---- | ---- | --0 |
Other non cashItems | 15.05%-21.68K | -415.49%-169.39K | ---117.71K | ---25.53K | ---32.86K | ---- | ---- | ---- |
Change In working capital | 380.15%184.41K | 274.68%181.09K | 247.67%130.87K | -109,806.67%-65.82K | -2,782.95%-103.67K | --37.64K | --60 | --3.86K |
-Change in receivables | -225.26%-15.76K | 125.99%9.7K | -980.35%-43.43K | --12.58K | ---37.31K | ---4.02K | --0 | --0 |
-Change in prepaid assets | 58.20%-12.13K | 181.21%122.29K | 3,574.97%140.49K | ---29.02K | ---150.58K | ---4.04K | --0 | --0 |
-Change in payables and accrued expense | 306.71%41.82K | -218.61%-30.7K | -89.81%4.66K | -33,821.67%-20.23K | 570.87%25.88K | --45.71K | --60 | --3.86K |
-Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6 |
-Change in other working capital | 684.79%170.47K | 36.82%79.81K | ---- | ---29.15K | --58.33K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||
Operating cash flow | 114.98%41.93K | 3.54%-623.31K | -426.69%-93.09K | -666,657.14%-279.95K | -64,615,400.00%-646.16K | --28.5K | --42 | ---1 |
Investing cash flow | ||||||||
Cash flow from continuing investing activities | -67.40%-247.51K | -303.61%-2.25M | -4,857.55%-1.41M | -147.86K | -557.66K | -28.53K | 0 | 0 |
Capital expenditure reported | -55.37%-223.51K | -507.11%-1.94M | ---1.11M | ---143.86K | ---319.2K | --0 | --0 | --0 |
Net PPE purchase and sale | ---- | -70.12%-308.86K | ---- | ---- | ---181.56K | ---- | ---- | ---- |
Net other investing changes | -500.00%-24K | 92.97%-4K | --0 | ---4K | ---56.9K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||
Investing cash flow | -67.40%-247.51K | -303.61%-2.25M | -4,857.55%-1.41M | ---147.86K | ---557.66K | ---28.53K | --0 | --0 |
Financing cash flow | ||||||||
Cash flow from continuing financing activities | -40.78%2.17M | 3.66M | 0 | |||||
Net common stock issuance | ---- | -40.56%2.32M | ---- | ---- | --3.9M | ---- | ---- | --0 |
Net other financing activities | ---- | 37.22%-150.38K | ---- | ---- | ---239.52K | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||
Financing cash flow | ---- | -40.78%2.17M | ---- | ---- | --3.66M | ---- | ---- | --0 |
Net cash flow | ||||||||
Beginning cash position | -28.75%1.75M | 40,944,433.33%2.46M | 5,635,583.33%2.03M | 40,944,433.33%2.46M | -700.00%-6 | --36 | ---6 | --1 |
Current changes in cash | 51.94%-205.59K | -128.75%-706.27K | -474.08%-1.51M | -1,018,704.76%-427.81K | 245,666,700.00%2.46M | --402.97K | --42 | ---1 |
End cash Position | -23.86%1.54M | -28.75%1.75M | 29.38%521.41K | 5,635,583.33%2.03M | --2.46M | --403K | --36 | --0 |
Free cash from | 57.15%-181.59K | -150.24%-2.87M | -4,567,878.79%-1.51M | -1,009,180.95%-423.81K | -114,691,300.00%-1.15M | ---33 | --42 | ---1 |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.